Carterra

About:

Carterra provides biotechnology solutions that develop and commercialize novel micro-array deposition technologies.

Top Investors: Tech Coast Angels, Ballast Point Ventures, PerkinElmer, Telegraph Hill Partners, PC Squared, LLC

Description:

Carterra provides biotechnology solutions that develop and commercialize novel micro-array deposition technologies. The company provides users with instruments and services, which enable multiplexing on planar array surfaces. It also offers Continuous Flow Microspotter (CFM), which includes an array printing instrument and a microfluidic print head. Its products include spot CFM printhead, which uses a network of microchannels to deposit samples at one time in a block; and CFM instrument, which uses built-in sensors and pumps to control the flow within the CFM print head. It was founded in 2005 and headquartered in Salt Lake City, Utah.

Total Funding Amount:

$38.1M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Salt Lake City, Utah, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)carterra-bio.com

Founders:

Bruce Gale, James Smith, Josh Eckman

Number of Employees:

51-100

Last Funding Date:

2020-12-14

IPO Status:

Private

Industries: